Analyst Ratings for SQZ Biotechnologies (SQZ)
Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
12/2/2022 | H.C. Wainwright | Emily Bodnar | Downgrade | Neutral (Buy) |
N/A (N/A) |
1.78 (0.44) |
-75.28% | Details |
12/1/2022 | BofA Securities | Tazeen Ahmad | Downgrade | Underperform (Buy) |
2.00 (9.00) |
2.51 (0.44) |
-82.47% | Details |